In line with this, our data demonstrated that the GERD group was characterized by an increase in the PAF, ROS, and RNS levels compared to the serum levels of the Sham + vehicle group (Figure 7A–C); however, their levels were significantly reduced following the treatment with bombesin at doses of 0.1, 0.5, and 1 mg/kg, as shown in Figure 7A–C. Here, GRP is linked to gastroesophageal reflux disease.